Sandra Jean Shin, M.D.

Anatomic Pathology and Clinical Pathology

Sandra Jean Shin, M.D.

Dr. Shin currently serves as Chief of Breast Pathology and Director of the Comprehensive Breast Pathology Consultation Service at the New York Presbyterian Hospital-Weill Cornell Medical College (NYPH-WCMC). She completed her anatomic and clinical pathology training and one-year breast pathology fellowship with Dr. Paul Peter Rosen at the New York Presbyterian Hospital-Cornell campus. After  a one year molecular pathology fellowship in the laboratory of Dr. Daniel M. Knowles, she joined the faculty in 2001.  For more than a decade, Dr. Shin has spent her time between clinical service work, translational research, and administrative duties.  Her research in breast disease has led to numerous peer-reviewed scientific publications including chapters in Diagnostic Immunohistochemistry (4 editions), World Health Organization (WHO) Classification of Tumors of the Breast (4th edition), and Breast Pathology (1st edition). She has also served as co-guest editor of Surgical Pathology Clinics; Breast Pathology Issue (2012) and authored a chapter in it entitled "Small Glandular Proliferations of the Breast".  Her scholarly activities in breast pathology have extended into national and international forums, notably her serving as a scientist grant reviewer for the Department of Defense Breast Cancer Research Program for many years and involvement in the United States & Canadian Academy of Pathology (USCAP) annual meeting as a abstract reviewer, moderator for the breast platform sessions, and expert panelist at the evening subspecialty conference. She participated in the World Health Organization (WHO) consensus editorial meeting in Lyon, France in 2012.  She currently serves on the expert breast pathology committee for the National Cancer Institute (NCI)/ The Cancer Genome Atlas (TCGA). She has given numerous invited lectures on the topic of breast disease across the country as well as internationally (including Mexico, South Korea, Hong Kong, Brazil, Puerto Rico, Bermuda) and is a reviewer or on the editorial board for multiple medical journals. She has been the director of long courses in breast pathology held at the annual meetings of College of American Pathologists (CAP) and American Society of Clinical Pathologists (ASCP). She is also the Pathology Residency Program Director and Breast Pathology Fellowship Director at the NYPH-WCMC.  She is funded  and Co-PI of an R01 NIH/NCI grant investigating the pathophysiological role of CUL4A in mammary tumoriogenesis.

Back to topBack To Top